Mobile Health Intervention for Acute Kidney Injury in Children
Trial Summary
What is the purpose of this trial?
The purpose of this study is to improve patient-centered care for acute kidney injury (AKI) in order to decrease the adverse health outcomes associated with this common condition.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
Is the Mobile Health Intervention for Acute Kidney Injury in Children safe?
The research articles do not provide specific safety data for the Mobile Health Intervention for Acute Kidney Injury in Children, but they discuss the use of digital applications and telemedicine for improving patient safety in related conditions, suggesting that such technologies can be safely used to enhance care.12345
How is the mobile health intervention for acute kidney injury in children different from other treatments?
Research Team
Rasheed Gbadegesin, MD
Principal Investigator
Duke University
Clarissa J Diamantidis, MD
Principal Investigator
Duke University
Eligibility Criteria
This trial is for children aged 1 to 18 years who have been diagnosed with acute kidney injury (AKI) while in the hospital. It's not suitable for kids over 18 years and 11 months, those with cognitive impairments that prevent consent, non-English speakers, or those who are legally blind or deaf.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Interviews
Interviews with families of patients diagnosed with AKI and providers to gather feedback on barriers and facilitators to pediatric AKI self-management
Tool Modification and Usability Testing
Modification of an existing educational tool based on interview feedback and usability testing
Pilot Testing
Pilot testing of the educational tool's impact on patient-centered care for pediatric AKI
Follow-up
Participants are monitored for safety and effectiveness after the intervention
Treatment Details
Interventions
- Mobile Health Educational Tool
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator